Q&A: Didi Discar on her role at UCB
Discar joined UCB Pharma this year as head of U.S. marketing for dermatology.
Pharma
Survey: Patients want more from pharma brand websites
Patients are looking for tools like doctor directories and the ability to book appointments on branded pharma websites.
GSK launches global creative review for pharma business
The fee on the account is estimated at $30 million.
Allergan brings bipolar experiences to life with out-of-control elevator
Allergan’s campaign for Vraylar portrays the highs and lows of bipolar disorder exactly as patients describe them.
Pfizer to combine off-patent business with Mylan
The new company will sell both Mylan’s branded and generic drugs and Pfizer’s off-patent treatments, such as Viagra.
Novartis looks to settle doc-bribery suit; CEO shares update on Zolgensma coverage
The Swiss drugmaker, which reported an otherwise upbeat second quarter, allocated a substantial reserve to settle bribery charges stemming from the suit.
AbbVie to buy Allergan as it prepares for a post-Humira world
Allergan comes with a $63 billion price tag.
Biotech Alkermes rebuilds public affairs team
Jeff Winton, who joined Alkermes last year as SVP of public affairs, was tasked with building out the company’s communications function.
Pfizer takes to Twitter to refute ‘Washington Post’ story
The drugmaker said that its decision not to pursue clinical trials on Alzheimer’s for Enbrel was based on science, not financial predictions.
Sanofi names former Novartis executive as CEO
Paul Hudson will replace the retiring Olivier Brandicourt in September.
